These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5880705)

  • 1. [On the mechanism of urea preparation on cerebrospinal fluid pressure in man].
    Dansker VL; Natochin IuV
    Biull Eksp Biol Med; 1965 Jul; 60(7):49-53. PubMed ID: 5880705
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of brain volume and intracranial pressure.
    Gilbert RG; Brindle GF
    Int Anesthesiol Clin; 1966; 4(4):819-23. PubMed ID: 5963726
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of intravenously administered hypertonic urea solution.
    Beks JW; Groen A; Huizinga T; Noordhoek KH; Smit JM; Walter WG
    Acta Neurochir (Wien); 1965; 13(1):1-10. PubMed ID: 5882543
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of hypertonic solutions on cerebrospinal fluid pressure in the lateral ventricle of the dog.
    Leonard JL; Redding RW
    Am J Vet Res; 1973 Feb; 34(2):213-9. PubMed ID: 4685545
    [No Abstract]   [Full Text] [Related]  

  • 5. Osmotic opening of tight junctions in cerebral endothelium.
    Brightman MW; Hori M; Rapoport SI; Reese TS; Westergaard E
    J Comp Neurol; 1973 Dec; 152(4):317-25. PubMed ID: 4784295
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the osmotherapeutic agent in neurosurgical field. II. Studies on lowering cerebrospinal fluid pressure of hypertonic mannitol solution].
    Suematsu K
    Sapporo Igaku Zasshi; 1965; 27(1):32-48. PubMed ID: 5327035
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
    Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
    Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid therapy in patients with cerebral tumors: benefits, mechanisms, problems, practicalities.
    Gutin PH
    Semin Oncol; 1975 Mar; 2(1):49-56. PubMed ID: 795033
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of space-occupying intracranial processes (brain edema, brain tumor) and low cerebrospinal fluid pressure].
    Hemmer R
    Bibl Psychiatr Neurol; 1969; 139():678-90. PubMed ID: 5406926
    [No Abstract]   [Full Text] [Related]  

  • 10. [The relationship between central venous and cerebrospinal fluid pressure and dehydration therapy].
    Sorokoumov VA
    Vopr Neirokhir; 1970; 34(6):25-32. PubMed ID: 5516359
    [No Abstract]   [Full Text] [Related]  

  • 11. Lack of autoregulatory response of the cerebral circulation after osmotic opening of the blood-brain barrier in dogs.
    Koźniewska E; Skolasińska K
    Acta Physiol Pol; 1980; 31(4):383-9. PubMed ID: 7446151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The blood-cerebrospinal fluid barrier].
    Ferlazzo A
    Pediatria (Napoli); 1982; 90(4):403-21. PubMed ID: 6763192
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ionic makeup of the cerebrospinal fluid during the infusion of osmotic diuretics].
    Manevich AZ; Sirovskiĭ EB; Krasnoperov IV
    Anesteziol Reanimatol; 1979; (5):3-7. PubMed ID: 507431
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative studies on osmolarity of cerebrospinal fluid and blood serum in newborn infants].
    Margies D; Jährig K
    Acta Biol Med Ger; 1971; 27(3):579-84. PubMed ID: 5147702
    [No Abstract]   [Full Text] [Related]  

  • 15. [Osmometry and clinical significance of osmolality].
    Frick PG
    Schweiz Med Wochenschr; 1968 Oct; 98(40):1562-4. PubMed ID: 4884127
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of intravenous infusion of hypertonic urea on the EEG of patients with intracranial space-occupying processes.
    Stein J; Krejcová H
    Electroencephalogr Clin Neurophysiol; 1969 Feb; 26(2):228. PubMed ID: 4183385
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of intracranial contents after hypertonic urea.
    ROSOMOFF HL
    J Neurosurg; 1962 Oct; 19():859-64. PubMed ID: 13975061
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of hypertonic solutions on the blood-brain barrier.
    Pollay M
    Neurology; 1975 Sep; 25(9):852-6. PubMed ID: 1172208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osmotic opening of the blood-brain barrier.
    Rapoport SI
    Ann Neurol; 1988 Nov; 24(5):677-84. PubMed ID: 3059990
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect produced by a lyophilized urea preparation upon EEG changes in patients with brain tumors].
    Dansker VL; Dubikaĭtis IuV; Stepanova TS
    Vopr Neirokhir; 1965; 29(6):27-9. PubMed ID: 5875658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.